The safety and effectiveness of once daily detemir in patients with type 2 diabetes previously failing oral agents:the Chinese cohort from SOL-VE^(TM) observational study  

作　　者：潘长玉 

机构地区：[1]Dept Endocrinol,Chinese PLA General Hosp

出　　处：《China Medical Abstracts(Internal Medicine)》2013年第1期21-21,共1页中国医学文摘（内科学分册（英文版）

摘　　要：Objective To evaluate the safety and effectiveness of initiating once-daily insulin detemir(Levemir) as add-on therapy in patients with type 2 diabetes mellitus(T2DM) who failed treatment of oral anti-diabetic drugs(OAD).Methods The present study was derived from the data

关 键 词：COHORT observational FASTING initiating FAILED REGIMEN enrolled Insulin PHYSICIAN baseline 

分 类 号：R587.1[医药卫生—内分泌]